nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—Electrocardiogram T wave inversion—Ifosfamide—germ cell cancer	0.0312	0.037	CcSEcCtD
Dexmedetomidine—Acute respiratory distress syndrome—Ifosfamide—germ cell cancer	0.024	0.0284	CcSEcCtD
Dexmedetomidine—Septic shock—Ifosfamide—germ cell cancer	0.0208	0.0246	CcSEcCtD
Dexmedetomidine—Septic shock—Etoposide—germ cell cancer	0.0164	0.0194	CcSEcCtD
Dexmedetomidine—Metabolic acidosis—Ifosfamide—germ cell cancer	0.0159	0.0188	CcSEcCtD
Dexmedetomidine—Nephropathy—Ifosfamide—germ cell cancer	0.0132	0.0156	CcSEcCtD
Dexmedetomidine—Metabolic acidosis—Etoposide—germ cell cancer	0.0125	0.0148	CcSEcCtD
Dexmedetomidine—Neuritis—Vinblastine—germ cell cancer	0.0116	0.0138	CcSEcCtD
Dexmedetomidine—Hypomagnesaemia—Bleomycin—germ cell cancer	0.0115	0.0137	CcSEcCtD
Dexmedetomidine—Acidosis—Ifosfamide—germ cell cancer	0.0113	0.0134	CcSEcCtD
Dexmedetomidine—Hypophosphataemia—Ifosfamide—germ cell cancer	0.0108	0.0128	CcSEcCtD
Dexmedetomidine—Nephropathy—Etoposide—germ cell cancer	0.0104	0.0123	CcSEcCtD
Dexmedetomidine—Hypoxia—Ifosfamide—germ cell cancer	0.00987	0.0117	CcSEcCtD
Dexmedetomidine—Hypophosphataemia—Cisplatin—germ cell cancer	0.0093	0.011	CcSEcCtD
Dexmedetomidine—Generalised oedema—Cisplatin—germ cell cancer	0.00908	0.0108	CcSEcCtD
Dexmedetomidine—Neuralgia—Ifosfamide—germ cell cancer	0.00902	0.0107	CcSEcCtD
Dexmedetomidine—Fluid overload—Cisplatin—germ cell cancer	0.00869	0.0103	CcSEcCtD
Dexmedetomidine—Ventricular arrhythmia—Ifosfamide—germ cell cancer	0.00847	0.01	CcSEcCtD
Dexmedetomidine—Pleural effusion—Ifosfamide—germ cell cancer	0.00818	0.00969	CcSEcCtD
Dexmedetomidine—CYP1A2—urine—germ cell cancer	0.00798	0.0514	CbGeAlD
Dexmedetomidine—Hypocalcaemia—Dactinomycin—germ cell cancer	0.00747	0.00885	CcSEcCtD
Dexmedetomidine—Delirium—Ifosfamide—germ cell cancer	0.00729	0.00863	CcSEcCtD
Dexmedetomidine—CYP2E1—urine—germ cell cancer	0.00718	0.0462	CbGeAlD
Dexmedetomidine—Wheezing—Bleomycin—germ cell cancer	0.00712	0.00843	CcSEcCtD
Dexmedetomidine—SLC6A2—ganglion—germ cell cancer	0.00708	0.0455	CbGeAlD
Dexmedetomidine—Hypocalcaemia—Ifosfamide—germ cell cancer	0.00685	0.00811	CcSEcCtD
Dexmedetomidine—Respiratory failure—Ifosfamide—germ cell cancer	0.00638	0.00756	CcSEcCtD
Dexmedetomidine—CYP1A1—skin epidermis—germ cell cancer	0.00638	0.041	CbGeAlD
Dexmedetomidine—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.00627	0.00742	CcSEcCtD
Dexmedetomidine—Nephropathy—Methotrexate—germ cell cancer	0.00623	0.00737	CcSEcCtD
Dexmedetomidine—Rigors—Etoposide—germ cell cancer	0.00606	0.00718	CcSEcCtD
Dexmedetomidine—Sepsis—Dactinomycin—germ cell cancer	0.00594	0.00703	CcSEcCtD
Dexmedetomidine—Apnoea—Etoposide—germ cell cancer	0.00584	0.00691	CcSEcCtD
Dexmedetomidine—CYP2D6—urine—germ cell cancer	0.00569	0.0366	CbGeAlD
Dexmedetomidine—Cardiovascular disorder—Etoposide—germ cell cancer	0.00563	0.00667	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Ifosfamide—germ cell cancer	0.00558	0.00661	CcSEcCtD
Dexmedetomidine—Sepsis—Ifosfamide—germ cell cancer	0.00544	0.00644	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Cisplatin—germ cell cancer	0.00531	0.00629	CcSEcCtD
Dexmedetomidine—Wheezing—Cisplatin—germ cell cancer	0.00525	0.00621	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00521	0.00616	CcSEcCtD
Dexmedetomidine—Fluid retention—Cisplatin—germ cell cancer	0.00513	0.00607	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Etoposide—germ cell cancer	0.00495	0.00586	CcSEcCtD
Dexmedetomidine—Renal failure acute—Ifosfamide—germ cell cancer	0.00493	0.00584	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Ifosfamide—germ cell cancer	0.0048	0.00568	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Vinblastine—germ cell cancer	0.00479	0.00567	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Vinblastine—germ cell cancer	0.00476	0.00564	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Vinblastine—germ cell cancer	0.00476	0.00564	CcSEcCtD
Dexmedetomidine—Hypoxia—Methotrexate—germ cell cancer	0.00467	0.00553	CcSEcCtD
Dexmedetomidine—Bronchospasm—Bleomycin—germ cell cancer	0.00453	0.00536	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00447	0.00529	CcSEcCtD
Dexmedetomidine—ADRA1D—telencephalon—germ cell cancer	0.00442	0.0284	CbGeAlD
Dexmedetomidine—Haemoglobin—Vinblastine—germ cell cancer	0.00438	0.00519	CcSEcCtD
Dexmedetomidine—Haemorrhage—Vinblastine—germ cell cancer	0.00436	0.00516	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Ifosfamide—germ cell cancer	0.00433	0.00512	CcSEcCtD
Dexmedetomidine—Sepsis—Etoposide—germ cell cancer	0.0043	0.00509	CcSEcCtD
Dexmedetomidine—Renal failure acute—Cisplatin—germ cell cancer	0.00425	0.00503	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Ifosfamide—germ cell cancer	0.00414	0.0049	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Etoposide—germ cell cancer	0.00413	0.00489	CcSEcCtD
Dexmedetomidine—Pneumonia—Bleomycin—germ cell cancer	0.00413	0.00489	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00404	0.00479	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Bleomycin—germ cell cancer	0.00402	0.00476	CcSEcCtD
Dexmedetomidine—Pleural effusion—Methotrexate—germ cell cancer	0.00387	0.00458	CcSEcCtD
Dexmedetomidine—Bronchospasm—Ifosfamide—germ cell cancer	0.00387	0.00458	CcSEcCtD
Dexmedetomidine—Pneumonia—Dactinomycin—germ cell cancer	0.00385	0.00456	CcSEcCtD
Dexmedetomidine—Haemoglobin—Bleomycin—germ cell cancer	0.0037	0.00438	CcSEcCtD
Dexmedetomidine—Haemorrhage—Bleomycin—germ cell cancer	0.00368	0.00436	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Cisplatin—germ cell cancer	0.00357	0.00423	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00355	0.0042	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00353	0.00418	CcSEcCtD
Dexmedetomidine—Pneumonia—Ifosfamide—germ cell cancer	0.00353	0.00418	CcSEcCtD
Dexmedetomidine—Anaemia—Vinblastine—germ cell cancer	0.00351	0.00415	CcSEcCtD
Dexmedetomidine—Apnoea—Methotrexate—germ cell cancer	0.0035	0.00414	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00346	0.00409	CcSEcCtD
Dexmedetomidine—Speech disorder—Methotrexate—germ cell cancer	0.00345	0.00408	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Ifosfamide—germ cell cancer	0.00344	0.00407	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.00344	0.00407	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Etoposide—germ cell cancer	0.00342	0.00405	CcSEcCtD
Dexmedetomidine—Chills—Bleomycin—germ cell cancer	0.0033	0.00391	CcSEcCtD
Dexmedetomidine—Sweating increased—Cisplatin—germ cell cancer	0.0033	0.00391	CcSEcCtD
Dexmedetomidine—Convulsion—Vinblastine—germ cell cancer	0.00329	0.00389	CcSEcCtD
Dexmedetomidine—Hypertension—Vinblastine—germ cell cancer	0.00328	0.00388	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.00326	0.00386	CcSEcCtD
Dexmedetomidine—Oliguria—Methotrexate—germ cell cancer	0.00322	0.00381	CcSEcCtD
Dexmedetomidine—Bradycardia—Ifosfamide—germ cell cancer	0.0032	0.00379	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00317	0.00375	CcSEcCtD
Dexmedetomidine—Haemoglobin—Ifosfamide—germ cell cancer	0.00316	0.00375	CcSEcCtD
Dexmedetomidine—Haemorrhage—Ifosfamide—germ cell cancer	0.00315	0.00373	CcSEcCtD
Dexmedetomidine—Hallucination—Ifosfamide—germ cell cancer	0.00313	0.00371	CcSEcCtD
Dexmedetomidine—Chills—Dactinomycin—germ cell cancer	0.00308	0.00365	CcSEcCtD
Dexmedetomidine—ADRA2C—trigeminal ganglion—germ cell cancer	0.00308	0.0198	CbGeAlD
Dexmedetomidine—SLC6A2—brainstem—germ cell cancer	0.00308	0.0198	CbGeAlD
Dexmedetomidine—Bronchospasm—Etoposide—germ cell cancer	0.00306	0.00362	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00303	0.00359	CcSEcCtD
Dexmedetomidine—Visual impairment—Ifosfamide—germ cell cancer	0.00303	0.00359	CcSEcCtD
Dexmedetomidine—Sweating increased—Etoposide—germ cell cancer	0.00303	0.00358	CcSEcCtD
Dexmedetomidine—Respiratory failure—Methotrexate—germ cell cancer	0.00302	0.00358	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00298	0.00353	CcSEcCtD
Dexmedetomidine—Anaemia—Bleomycin—germ cell cancer	0.00296	0.00351	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Cisplatin—germ cell cancer	0.00296	0.00351	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00296	0.00351	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00292	0.00346	CcSEcCtD
Dexmedetomidine—Angiopathy—Ifosfamide—germ cell cancer	0.00286	0.00338	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00284	0.00336	CcSEcCtD
Dexmedetomidine—Chills—Ifosfamide—germ cell cancer	0.00282	0.00334	CcSEcCtD
Dexmedetomidine—ADRA1B—head—germ cell cancer	0.00281	0.0181	CbGeAlD
Dexmedetomidine—Arrhythmia—Ifosfamide—germ cell cancer	0.00281	0.00333	CcSEcCtD
Dexmedetomidine—ADRA1D—endocrine gland—germ cell cancer	0.00279	0.0179	CbGeAlD
Dexmedetomidine—Pneumonia—Etoposide—germ cell cancer	0.00279	0.0033	CcSEcCtD
Dexmedetomidine—Anaemia—Dactinomycin—germ cell cancer	0.00276	0.00327	CcSEcCtD
Dexmedetomidine—Bradycardia—Cisplatin—germ cell cancer	0.00276	0.00327	CcSEcCtD
Dexmedetomidine—Mental disorder—Ifosfamide—germ cell cancer	0.00276	0.00327	CcSEcCtD
Dexmedetomidine—ADRA1D—head—germ cell cancer	0.00275	0.0177	CbGeAlD
Dexmedetomidine—Malnutrition—Ifosfamide—germ cell cancer	0.00274	0.00324	CcSEcCtD
Dexmedetomidine—SLC6A2—telencephalon—germ cell cancer	0.00273	0.0176	CbGeAlD
Dexmedetomidine—Acute coronary syndrome—Etoposide—germ cell cancer	0.00273	0.00323	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Etoposide—germ cell cancer	0.00271	0.00321	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Etoposide—germ cell cancer	0.00271	0.00321	CcSEcCtD
Dexmedetomidine—Constipation—Vinblastine—germ cell cancer	0.00265	0.00314	CcSEcCtD
Dexmedetomidine—Pain—Vinblastine—germ cell cancer	0.00265	0.00314	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Methotrexate—germ cell cancer	0.00264	0.00313	CcSEcCtD
Dexmedetomidine—Confusional state—Bleomycin—germ cell cancer	0.00264	0.00312	CcSEcCtD
Dexmedetomidine—Visual impairment—Cisplatin—germ cell cancer	0.00262	0.0031	CcSEcCtD
Dexmedetomidine—Infection—Bleomycin—germ cell cancer	0.0026	0.00308	CcSEcCtD
Dexmedetomidine—SLC6A2—decidua—germ cell cancer	0.00259	0.0166	CbGeAlD
Dexmedetomidine—Sepsis—Methotrexate—germ cell cancer	0.00257	0.00305	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00256	0.00303	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Vinblastine—germ cell cancer	0.00255	0.00302	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00253	0.003	CcSEcCtD
Dexmedetomidine—Anaemia—Ifosfamide—germ cell cancer	0.00253	0.003	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Cisplatin—germ cell cancer	0.00252	0.00298	CcSEcCtD
Dexmedetomidine—Agitation—Ifosfamide—germ cell cancer	0.00252	0.00298	CcSEcCtD
Dexmedetomidine—ADRA2A—trigeminal ganglion—germ cell cancer	0.00246	0.0158	CbGeAlD
Dexmedetomidine—Abdominal pain—Vinblastine—germ cell cancer	0.00245	0.0029	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00245	0.0029	CcSEcCtD
Dexmedetomidine—Hypotension—Bleomycin—germ cell cancer	0.00244	0.00289	CcSEcCtD
Dexmedetomidine—Infection—Dactinomycin—germ cell cancer	0.00242	0.00287	CcSEcCtD
Dexmedetomidine—Arrhythmia—Cisplatin—germ cell cancer	0.00242	0.00287	CcSEcCtD
Dexmedetomidine—ADRA2C—telencephalon—germ cell cancer	0.00242	0.0156	CbGeAlD
Dexmedetomidine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00239	0.00283	CcSEcCtD
Dexmedetomidine—Convulsion—Ifosfamide—germ cell cancer	0.00237	0.00281	CcSEcCtD
Dexmedetomidine—Hypertension—Ifosfamide—germ cell cancer	0.00237	0.0028	CcSEcCtD
Dexmedetomidine—Malnutrition—Cisplatin—germ cell cancer	0.00236	0.0028	CcSEcCtD
Dexmedetomidine—Dyspnoea—Bleomycin—germ cell cancer	0.00233	0.00276	CcSEcCtD
Dexmedetomidine—Renal failure acute—Methotrexate—germ cell cancer	0.00233	0.00276	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Etoposide—germ cell cancer	0.00231	0.00273	CcSEcCtD
Dexmedetomidine—ADRA2C—decidua—germ cell cancer	0.00229	0.0147	CbGeAlD
Dexmedetomidine—SLC6A2—gonad—germ cell cancer	0.00228	0.0147	CbGeAlD
Dexmedetomidine—Angiopathy—Etoposide—germ cell cancer	0.00226	0.00267	CcSEcCtD
Dexmedetomidine—Confusional state—Ifosfamide—germ cell cancer	0.00225	0.00267	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Etoposide—germ cell cancer	0.00224	0.00265	CcSEcCtD
Dexmedetomidine—Pain—Bleomycin—germ cell cancer	0.00224	0.00265	CcSEcCtD
Dexmedetomidine—Chills—Etoposide—germ cell cancer	0.00223	0.00264	CcSEcCtD
Dexmedetomidine—Infection—Ifosfamide—germ cell cancer	0.00222	0.00263	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00219	0.00259	CcSEcCtD
Dexmedetomidine—Anaemia—Cisplatin—germ cell cancer	0.00218	0.00259	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00216	0.00256	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Bleomycin—germ cell cancer	0.00216	0.00255	CcSEcCtD
Dexmedetomidine—SLC6A2—medulla oblongata—germ cell cancer	0.00215	0.0138	CbGeAlD
Dexmedetomidine—Diarrhoea—Vinblastine—germ cell cancer	0.00212	0.00251	CcSEcCtD
Dexmedetomidine—Hypotension—Ifosfamide—germ cell cancer	0.00209	0.00247	CcSEcCtD
Dexmedetomidine—Pain—Dactinomycin—germ cell cancer	0.00209	0.00247	CcSEcCtD
Dexmedetomidine—Body temperature increased—Bleomycin—germ cell cancer	0.00207	0.00245	CcSEcCtD
Dexmedetomidine—Dizziness—Vinblastine—germ cell cancer	0.00205	0.00243	CcSEcCtD
Dexmedetomidine—Convulsion—Cisplatin—germ cell cancer	0.00205	0.00242	CcSEcCtD
Dexmedetomidine—ADRA1B—brain—germ cell cancer	0.00204	0.0131	CbGeAlD
Dexmedetomidine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00201	0.00238	CcSEcCtD
Dexmedetomidine—ADRA2C—uterus—germ cell cancer	0.00201	0.0129	CbGeAlD
Dexmedetomidine—Anxiety—Cisplatin—germ cell cancer	0.002	0.00237	CcSEcCtD
Dexmedetomidine—Anaemia—Etoposide—germ cell cancer	0.002	0.00237	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.002	0.00236	CcSEcCtD
Dexmedetomidine—ADRA1D—brain—germ cell cancer	0.00199	0.0128	CbGeAlD
Dexmedetomidine—Dyspnoea—Ifosfamide—germ cell cancer	0.00199	0.00236	CcSEcCtD
Dexmedetomidine—Somnolence—Ifosfamide—germ cell cancer	0.00199	0.00235	CcSEcCtD
Dexmedetomidine—SLC6A2—adrenal gland—germ cell cancer	0.00199	0.0128	CbGeAlD
Dexmedetomidine—CYP1A1—skin of body—germ cell cancer	0.00198	0.0127	CbGeAlD
Dexmedetomidine—Vomiting—Vinblastine—germ cell cancer	0.00197	0.00233	CcSEcCtD
Dexmedetomidine—ADRA2C—pituitary gland—germ cell cancer	0.00197	0.0127	CbGeAlD
Dexmedetomidine—Headache—Vinblastine—germ cell cancer	0.00194	0.0023	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00193	0.00229	CcSEcCtD
Dexmedetomidine—ADRA2A—telencephalon—germ cell cancer	0.00193	0.0124	CbGeAlD
Dexmedetomidine—Abdominal pain—Dactinomycin—germ cell cancer	0.00193	0.00228	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dactinomycin—germ cell cancer	0.00193	0.00228	CcSEcCtD
Dexmedetomidine—Infection—Cisplatin—germ cell cancer	0.00192	0.00227	CcSEcCtD
Dexmedetomidine—Constipation—Ifosfamide—germ cell cancer	0.00191	0.00226	CcSEcCtD
Dexmedetomidine—Pain—Ifosfamide—germ cell cancer	0.00191	0.00226	CcSEcCtD
Dexmedetomidine—ADRA2C—medulla oblongata—germ cell cancer	0.0019	0.0122	CbGeAlD
Dexmedetomidine—CYP2E1—telencephalon—germ cell cancer	0.00189	0.0121	CbGeAlD
Dexmedetomidine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00189	0.00223	CcSEcCtD
Dexmedetomidine—Tachycardia—Cisplatin—germ cell cancer	0.00188	0.00223	CcSEcCtD
Dexmedetomidine—Convulsion—Etoposide—germ cell cancer	0.00188	0.00222	CcSEcCtD
Dexmedetomidine—Hypertension—Etoposide—germ cell cancer	0.00187	0.00221	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00186	0.00221	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00184	0.00218	CcSEcCtD
Dexmedetomidine—Nausea—Vinblastine—germ cell cancer	0.00184	0.00218	CcSEcCtD
Dexmedetomidine—ADRA2A—decidua—germ cell cancer	0.00183	0.0118	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00183	0.00217	CcSEcCtD
Dexmedetomidine—Hypotension—Cisplatin—germ cell cancer	0.0018	0.00213	CcSEcCtD
Dexmedetomidine—Confusional state—Etoposide—germ cell cancer	0.00178	0.00211	CcSEcCtD
Dexmedetomidine—Abdominal pain—Ifosfamide—germ cell cancer	0.00177	0.00209	CcSEcCtD
Dexmedetomidine—Body temperature increased—Ifosfamide—germ cell cancer	0.00177	0.00209	CcSEcCtD
Dexmedetomidine—ADRA2C—adrenal gland—germ cell cancer	0.00176	0.0113	CbGeAlD
Dexmedetomidine—Infection—Etoposide—germ cell cancer	0.00175	0.00208	CcSEcCtD
Dexmedetomidine—ADRA2C—midbrain—germ cell cancer	0.00174	0.0112	CbGeAlD
Dexmedetomidine—Thrombocytopenia—Etoposide—germ cell cancer	0.00173	0.00205	CcSEcCtD
Dexmedetomidine—Tachycardia—Etoposide—germ cell cancer	0.00172	0.00204	CcSEcCtD
Dexmedetomidine—SLC6A2—endocrine gland—germ cell cancer	0.00172	0.0111	CbGeAlD
Dexmedetomidine—Dyspnoea—Cisplatin—germ cell cancer	0.00172	0.00204	CcSEcCtD
Dexmedetomidine—CYP1A1—uterus—germ cell cancer	0.00172	0.011	CbGeAlD
Dexmedetomidine—Hyperhidrosis—Etoposide—germ cell cancer	0.00171	0.00202	CcSEcCtD
Dexmedetomidine—SLC6A2—head—germ cell cancer	0.0017	0.0109	CbGeAlD
Dexmedetomidine—ADRA2C—spinal cord—germ cell cancer	0.00169	0.0109	CbGeAlD
Dexmedetomidine—CYP2D6—brainstem—germ cell cancer	0.00168	0.0108	CbGeAlD
Dexmedetomidine—Diarrhoea—Dactinomycin—germ cell cancer	0.00167	0.00198	CcSEcCtD
Dexmedetomidine—Pneumonia—Methotrexate—germ cell cancer	0.00167	0.00198	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00166	0.00197	CcSEcCtD
Dexmedetomidine—Vomiting—Bleomycin—germ cell cancer	0.00166	0.00197	CcSEcCtD
Dexmedetomidine—Hypotension—Etoposide—germ cell cancer	0.00165	0.00195	CcSEcCtD
Dexmedetomidine—Rash—Bleomycin—germ cell cancer	0.00165	0.00195	CcSEcCtD
Dexmedetomidine—Pain—Cisplatin—germ cell cancer	0.00165	0.00195	CcSEcCtD
Dexmedetomidine—Dermatitis—Bleomycin—germ cell cancer	0.00165	0.00195	CcSEcCtD
Dexmedetomidine—SLC6A2—testis—germ cell cancer	0.00164	0.0106	CbGeAlD
Dexmedetomidine—ADRA2C—female gonad—germ cell cancer	0.00164	0.0106	CbGeAlD
Dexmedetomidine—ADRA2A—gonad—germ cell cancer	0.00161	0.0104	CbGeAlD
Dexmedetomidine—ADRA2A—uterus—germ cell cancer	0.0016	0.0103	CbGeAlD
Dexmedetomidine—Feeling abnormal—Cisplatin—germ cell cancer	0.00159	0.00188	CcSEcCtD
Dexmedetomidine—Dyspnoea—Etoposide—germ cell cancer	0.00157	0.00186	CcSEcCtD
Dexmedetomidine—ADRA2A—pituitary gland—germ cell cancer	0.00157	0.0101	CbGeAlD
Dexmedetomidine—Somnolence—Etoposide—germ cell cancer	0.00157	0.00186	CcSEcCtD
Dexmedetomidine—Nausea—Bleomycin—germ cell cancer	0.00155	0.00184	CcSEcCtD
Dexmedetomidine—Vomiting—Dactinomycin—germ cell cancer	0.00155	0.00184	CcSEcCtD
Dexmedetomidine—Rash—Dactinomycin—germ cell cancer	0.00154	0.00182	CcSEcCtD
Dexmedetomidine—Diarrhoea—Ifosfamide—germ cell cancer	0.00153	0.00181	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00152	0.00181	CcSEcCtD
Dexmedetomidine—Body temperature increased—Cisplatin—germ cell cancer	0.00152	0.0018	CcSEcCtD
Dexmedetomidine—ADRA2A—medulla oblongata—germ cell cancer	0.00152	0.00975	CbGeAlD
Dexmedetomidine—Pain—Etoposide—germ cell cancer	0.00151	0.00179	CcSEcCtD
Dexmedetomidine—Constipation—Etoposide—germ cell cancer	0.00151	0.00179	CcSEcCtD
Dexmedetomidine—ADRA2C—head—germ cell cancer	0.00151	0.00969	CbGeAlD
Dexmedetomidine—Haemoglobin—Methotrexate—germ cell cancer	0.0015	0.00177	CcSEcCtD
Dexmedetomidine—CYP2D6—telencephalon—germ cell cancer	0.00149	0.00962	CbGeAlD
Dexmedetomidine—Haemorrhage—Methotrexate—germ cell cancer	0.00149	0.00176	CcSEcCtD
Dexmedetomidine—CYP2E1—medulla oblongata—germ cell cancer	0.00148	0.00954	CbGeAlD
Dexmedetomidine—Dizziness—Ifosfamide—germ cell cancer	0.00148	0.00175	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Etoposide—germ cell cancer	0.00146	0.00172	CcSEcCtD
Dexmedetomidine—ADRA2C—testis—germ cell cancer	0.00145	0.00936	CbGeAlD
Dexmedetomidine—Nausea—Dactinomycin—germ cell cancer	0.00145	0.00172	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Etoposide—germ cell cancer	0.00144	0.00171	CcSEcCtD
Dexmedetomidine—Visual impairment—Methotrexate—germ cell cancer	0.00143	0.0017	CcSEcCtD
Dexmedetomidine—Vomiting—Ifosfamide—germ cell cancer	0.00142	0.00168	CcSEcCtD
Dexmedetomidine—Rash—Ifosfamide—germ cell cancer	0.00141	0.00167	CcSEcCtD
Dexmedetomidine—Dermatitis—Ifosfamide—germ cell cancer	0.00141	0.00167	CcSEcCtD
Dexmedetomidine—CYP1A1—female gonad—germ cell cancer	0.0014	0.00903	CbGeAlD
Dexmedetomidine—ADRA2A—adrenal gland—germ cell cancer	0.0014	0.00903	CbGeAlD
Dexmedetomidine—Body temperature increased—Etoposide—germ cell cancer	0.0014	0.00165	CcSEcCtD
Dexmedetomidine—Abdominal pain—Etoposide—germ cell cancer	0.0014	0.00165	CcSEcCtD
Dexmedetomidine—ADRA2A—midbrain—germ cell cancer	0.00139	0.00892	CbGeAlD
Dexmedetomidine—Cardiac disorder—Methotrexate—germ cell cancer	0.00138	0.00164	CcSEcCtD
Dexmedetomidine—CYP2E1—adrenal gland—germ cell cancer	0.00137	0.00883	CbGeAlD
Dexmedetomidine—ADRA2A—spinal cord—germ cell cancer	0.00135	0.0087	CbGeAlD
Dexmedetomidine—Angiopathy—Methotrexate—germ cell cancer	0.00135	0.0016	CcSEcCtD
Dexmedetomidine—ADRA2C—cerebellum—germ cell cancer	0.00134	0.00864	CbGeAlD
Dexmedetomidine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00134	0.00159	CcSEcCtD
Dexmedetomidine—Chills—Methotrexate—germ cell cancer	0.00134	0.00158	CcSEcCtD
Dexmedetomidine—Nausea—Ifosfamide—germ cell cancer	0.00133	0.00157	CcSEcCtD
Dexmedetomidine—CYP1A2—endocrine gland—germ cell cancer	0.00132	0.00852	CbGeAlD
Dexmedetomidine—CYP2E1—spinal cord—germ cell cancer	0.00132	0.00851	CbGeAlD
Dexmedetomidine—Diarrhoea—Cisplatin—germ cell cancer	0.00132	0.00156	CcSEcCtD
Dexmedetomidine—ADRA2A—female gonad—germ cell cancer	0.00131	0.00842	CbGeAlD
Dexmedetomidine—CYP1A1—endocrine gland—germ cell cancer	0.00131	0.0084	CbGeAlD
Dexmedetomidine—Mental disorder—Methotrexate—germ cell cancer	0.0013	0.00154	CcSEcCtD
Dexmedetomidine—Malnutrition—Methotrexate—germ cell cancer	0.0013	0.00153	CcSEcCtD
Dexmedetomidine—CYP1A1—head—germ cell cancer	0.00129	0.00829	CbGeAlD
Dexmedetomidine—SLC6A2—brain—germ cell cancer	0.00123	0.00793	CbGeAlD
Dexmedetomidine—Vomiting—Cisplatin—germ cell cancer	0.00123	0.00145	CcSEcCtD
Dexmedetomidine—ADRA2A—endocrine gland—germ cell cancer	0.00122	0.00783	CbGeAlD
Dexmedetomidine—Rash—Cisplatin—germ cell cancer	0.00122	0.00144	CcSEcCtD
Dexmedetomidine—Dermatitis—Cisplatin—germ cell cancer	0.00121	0.00144	CcSEcCtD
Dexmedetomidine—Diarrhoea—Etoposide—germ cell cancer	0.00121	0.00143	CcSEcCtD
Dexmedetomidine—ADRA2A—head—germ cell cancer	0.0012	0.00773	CbGeAlD
Dexmedetomidine—Anaemia—Methotrexate—germ cell cancer	0.0012	0.00142	CcSEcCtD
Dexmedetomidine—CYP2E1—endocrine gland—germ cell cancer	0.00119	0.00766	CbGeAlD
Dexmedetomidine—SLC6A2—lymph node—germ cell cancer	0.00119	0.00766	CbGeAlD
Dexmedetomidine—CYP2E1—head—germ cell cancer	0.00118	0.00756	CbGeAlD
Dexmedetomidine—Dizziness—Etoposide—germ cell cancer	0.00117	0.00138	CcSEcCtD
Dexmedetomidine—ADRA2A—testis—germ cell cancer	0.00116	0.00747	CbGeAlD
Dexmedetomidine—Nausea—Cisplatin—germ cell cancer	0.00115	0.00136	CcSEcCtD
Dexmedetomidine—CYP2E1—testis—germ cell cancer	0.00114	0.00731	CbGeAlD
Dexmedetomidine—Convulsion—Methotrexate—germ cell cancer	0.00112	0.00133	CcSEcCtD
Dexmedetomidine—Vomiting—Etoposide—germ cell cancer	0.00112	0.00133	CcSEcCtD
Dexmedetomidine—Rash—Etoposide—germ cell cancer	0.00111	0.00132	CcSEcCtD
Dexmedetomidine—Dermatitis—Etoposide—germ cell cancer	0.00111	0.00132	CcSEcCtD
Dexmedetomidine—Headache—Etoposide—germ cell cancer	0.00111	0.00131	CcSEcCtD
Dexmedetomidine—ADRA2C—brain—germ cell cancer	0.00109	0.00702	CbGeAlD
Dexmedetomidine—ADRA2A—cerebellum—germ cell cancer	0.00107	0.0069	CbGeAlD
Dexmedetomidine—Confusional state—Methotrexate—germ cell cancer	0.00107	0.00126	CcSEcCtD
Dexmedetomidine—ADRA2C—lymph node—germ cell cancer	0.00105	0.00678	CbGeAlD
Dexmedetomidine—Infection—Methotrexate—germ cell cancer	0.00105	0.00124	CcSEcCtD
Dexmedetomidine—Nausea—Etoposide—germ cell cancer	0.00105	0.00124	CcSEcCtD
Dexmedetomidine—CYP2E1—cerebellum—germ cell cancer	0.00105	0.00675	CbGeAlD
Dexmedetomidine—Thrombocytopenia—Methotrexate—germ cell cancer	0.00104	0.00123	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00102	0.00121	CcSEcCtD
Dexmedetomidine—CYP2D6—female gonad—germ cell cancer	0.00101	0.00652	CbGeAlD
Dexmedetomidine—Hypotension—Methotrexate—germ cell cancer	0.000989	0.00117	CcSEcCtD
Dexmedetomidine—Dyspnoea—Methotrexate—germ cell cancer	0.000943	0.00112	CcSEcCtD
Dexmedetomidine—CYP2D6—endocrine gland—germ cell cancer	0.000943	0.00607	CbGeAlD
Dexmedetomidine—Somnolence—Methotrexate—germ cell cancer	0.00094	0.00111	CcSEcCtD
Dexmedetomidine—CYP1A1—brain—germ cell cancer	0.000934	0.00601	CbGeAlD
Dexmedetomidine—CYP2D6—head—germ cell cancer	0.000931	0.00599	CbGeAlD
Dexmedetomidine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000913	0.00108	CcSEcCtD
Dexmedetomidine—Pain—Methotrexate—germ cell cancer	0.000905	0.00107	CcSEcCtD
Dexmedetomidine—CYP1A1—lymph node—germ cell cancer	0.000903	0.00581	CbGeAlD
Dexmedetomidine—CYP2D6—testis—germ cell cancer	0.000899	0.00578	CbGeAlD
Dexmedetomidine—Feeling abnormal—Methotrexate—germ cell cancer	0.000872	0.00103	CcSEcCtD
Dexmedetomidine—ADRA2A—brain—germ cell cancer	0.000871	0.0056	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000865	0.00102	CcSEcCtD
Dexmedetomidine—CYP2E1—brain—germ cell cancer	0.000852	0.00548	CbGeAlD
Dexmedetomidine—ADRA2A—lymph node—germ cell cancer	0.000841	0.00541	CbGeAlD
Dexmedetomidine—Body temperature increased—Methotrexate—germ cell cancer	0.000836	0.00099	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methotrexate—germ cell cancer	0.000836	0.00099	CcSEcCtD
Dexmedetomidine—CYP2D6—cerebellum—germ cell cancer	0.00083	0.00534	CbGeAlD
Dexmedetomidine—Diarrhoea—Methotrexate—germ cell cancer	0.000724	0.000857	CcSEcCtD
Dexmedetomidine—Dizziness—Methotrexate—germ cell cancer	0.0007	0.000828	CcSEcCtD
Dexmedetomidine—CYP2D6—brain—germ cell cancer	0.000675	0.00434	CbGeAlD
Dexmedetomidine—Vomiting—Methotrexate—germ cell cancer	0.000673	0.000796	CcSEcCtD
Dexmedetomidine—Rash—Methotrexate—germ cell cancer	0.000667	0.00079	CcSEcCtD
Dexmedetomidine—Dermatitis—Methotrexate—germ cell cancer	0.000666	0.000789	CcSEcCtD
Dexmedetomidine—Headache—Methotrexate—germ cell cancer	0.000663	0.000785	CcSEcCtD
Dexmedetomidine—Nausea—Methotrexate—germ cell cancer	0.000628	0.000744	CcSEcCtD
